Pyridostigmine

Pyridostigmine

Pyridostigmine tablets, commonly used in the treatment of myasthenia gravis.

Pyridostigmine

Pyridostigmine is a medication primarily used for the treatment of myasthenia gravis, a chronic autoimmune neuromuscular disease. It is also used in conjunction with atropine to reverse the effects of non-depolarizing neuromuscular blocking agents.

Overview

Pyridostigmine belongs to a class of drugs known as cholinesterase inhibitors. It enhances communication between nerves and muscles, improving muscle strength in patients with myasthenia gravis.

Uses

Myasthenia Gravis

Pyridostigmine is a cornerstone in the management of myasthenia gravis, helping to alleviate muscle weakness.

Neuromuscular Blockade Reversal

In anesthesia, pyridostigmine is used with atropine to terminate the effects of non-depolarizing neuromuscular blocking drugs.

Administration

Pyridostigmine can be administered orally or via injection. Oral administration is most common, with effects typically beginning within 45 minutes and lasting up to 6 hours.

History

Pyridostigmine was first patented in 1945 and introduced for medical use in 1955. Since then, it has become a vital medication in neurology and anesthesiology.

Global Availability

Listed on the World Health Organization's List of Essential Medicines, pyridostigmine is recognized as a critical medication in healthcare systems worldwide. It is available as a generic medication, ensuring broader accessibility.

Pyridostigmine Resources
Latest articles Most recent articles Ongoing trials	Wikipedia